Egypt, September 2013, Cancer medicines
|
Originator brand medicines surveyed Egypt, September 2013, Cancer medicines
|
|
||||||
| Medicine name | Strength | Dosage form | Medicine list | EML | Originator brand name | Originator brand manufacturer | International reference price source MSH2012 (US $) |
| Carboplatin | 450 mg | vial | Supplementary | Yes | 34.7129 | ||
| Cisplatin | 10 mg/ml | injection | Supplementary | No | 0.4390 | ||
| Etoposide | 20 mg/ml | injection | Supplementary | Yes | 0.8480 | ||
| Imatinib | 400 mg | cap/tab | Supplementary | No | Glivec | Novartis | 52.5000 |
| Oxaliplatin | 50 mg | vial | Supplementary | No | Eloxatin | Sanofi Winthrop/Ramco | 74.8650 |